PSIL Holdings — AdvisorShares Psychedelics ETF
All 29 reported holdings of AdvisorShares Psychedelics ETF (PSIL) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Relmada Therapeutics Inc. | 10.17% | $2.06M |
| Ataibeckley, Inc. | 9.92% | $2.01M |
| Definium Therapeutics, Inc. | 8.52% | $1.73M |
| Drey Inst Pref Gov Mm-M | 7.89% | $1.60M |
| Compass Pathways plc | 6.74% | $1.36M |
| Neurocrine Biosciences Inc | 4.66% | $944.58K |
| Gh Research Plc | 4.65% | $942.50K |
| Cybin Inc | 4.64% | $938.90K |
| Alkermes PLC | 4.60% | $932.41K |
| Johnson & Johnson | 4.56% | $923.49K |
| Alto Neuroscience Inc | 4.55% | $922.20K |
| Bright Minds Biosciences Inc | 4.55% | $920.37K |
| AbbVie Inc. | 4.47% | $905.85K |
| Supernus Pharmaceuticals, Inc | 4.46% | $902.15K |
| NRX Pharmaceuticals Inc | 4.42% | $895.59K |
| Neuronetics Inc | 4.42% | $894.93K |
| Blackrock Treasury Trust | 3.96% | $801.42K |
| Neuphoria Therapeutics Inc | 3.12% | $632.34K |
| Quantum Biopharma Ltd | 2.59% | $524.49K |
| Pasithea Therapeutics Corp. | 1.24% | $250.36K |
| Silo Pharma Inc | 1.18% | $238.83K |
| Vistagen Therapeutics, Inc. | 0.78% | $158.37K |
| Incannex Healthcare, Inc. | 0.36% | $73.51K |
| Numinus Wellness Inc | 0.32% | $64.31K |
| Enveric Biosciences Inc | 0.16% | $32.93K |
| Clearmind Medicine Inc. | 0.04% | $7.65K |
| Quantum Biopharma | 0.00% | $0 |
| Unbuzzd Wellness, Inc. | 0.00% | $0 |
| Sage Therapeutics, Inc. | 0.00% | $0 |
PSIL overview: performance, fees, allocation and SEC filings